Company: BLUWU
Filing Date: 2025-02-20
Form Type: S-1
Source: 0001493152-25-007630
Chunk: 291

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-02-20
Form: S-1
Chunk 291
---
or $4,600,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable to the          
 underwriters upon the closing of this offering. Also includes $0.35 per unit, or 3.5% of the gross proceeds of the offering, or $7,000,000 
 in the aggregate (or up to $8,050,000 in the aggregate if the underwriters’ over-allotment option is exercised in full) payable            
 to BTIG, LLC for deferred underwriting commissions to be deposited in a trust account located in the United States and released to BTIG,   
 LLC only upon the completion of an initial business combination. The deferred underwriting commissions will be payable as follows: (i)     
 $0.30 per unit sold in this offering will be paid to BTIG, LLC in cash upon the closing of the initial business combination and (ii)       
 $0.05 per unit sold in this offering will be payable to BTIG, LLC in cash (the “Allocable Amount”), provided that we and                   
 our sponsor have the right, in our and our sponsor’s discretion, to reallocate any portion of the Allocable Amount to third parties        
 not participating in this offering (but who are members of FINRA) that assist us in consummating the initial business combination.         |

If we do not complete our initial business combination within the completion window and subsequently liquidate, the trustee and the underwriters have agreed that (i) they will forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in the trust account upon liquidation, and (ii) that the deferred underwriting discounts and commissions will be distributed on a pro rata basis, including interest earned on the funds held in the trust account (less taxes payable), to the public shareholders.

Expression of Interest

The non-managing sponsor investors have expressed to us an interest in purchasing up to an aggregate of approximately $[_____] million of the units in this offering at the offering price (considering the exercise in full of the underwriters’ over-allotment option), or up to [____]% of this offering. None of the non-managing sponsor investors has expressed to us an interest in purchasing more than 9.9% of the units to be sold in this offering. There can be no assurance that the non-managing sponsor investors will acquire any units, either directly or indirectly, in this offering, or as